Clinical Drug Investigation · 2004 · 26 citations · 31 references
PharmacyNeurologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisPharmacoeconomic ModelingCost-effectiveness ComparisonDemyelinating DiseasesEconomic EvaluationModel-based Economic EvaluationMultiple SclerosisMultiple Sclerosis PharmacotherapyMultiple Sclerosis TherapyRelapsing-remitting Multiple Sclerosis Treatment
31
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
Neurology · 1993 · 2.1K citations
Pharmacy, Neurology, Pharmacotherapy +14
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text
Pharmacy, Neurology, Pharmacotherapy +14